Just sayin', annual report's emphasis sits squarely with Rett's and Fragile X - TBI trial (10 years plus in the making) gets scant mention in comparison. Doesn't particularly elevate the excitement juices re the forthcoming Phase II ann. Trading activity not indicative of booming times ahead. Market asleep or discerningly astute? We will soon know.
Ann: Annual Report to shareholders-NEU.AX, page-27
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.54 |
Change
0.280(2.28%) |
Mkt cap ! $1.559B | |||
| Open | High | Low | Value | Volume |
| $12.52 | $12.73 | $12.26 | $8.152M | 652.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 665 | $12.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.55 | 235 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |